HomeIBRX • NASDAQ
add
Immunitybio Inc
Previous close
$2.63
Day range
$2.69 - $3.04
Year range
$2.28 - $10.53
Market cap
2.55B USD
Avg Volume
6.55M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 7.55M | 5,333.09% |
Operating expense | 76.95M | -9.08% |
Net income | -59.16M | 74.65% |
Net profit margin | -783.40 | 99.53% |
Earnings per share | -0.08 | — |
EBITDA | -65.26M | 18.36% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 149.81M | -43.78% |
Total assets | 382.93M | -24.09% |
Total liabilities | 871.06M | -20.11% |
Total equity | -488.13M | — |
Shares outstanding | 853.44M | — |
Price to book | -4.61 | — |
Return on assets | -46.42% | — |
Return on capital | -60.22% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -59.16M | 74.65% |
Cash from operations | -85.14M | 26.14% |
Cash from investing | 9.83M | 337.26% |
Cash from financing | 106.93M | -46.68% |
Net change in cash | 31.61M | -63.87% |
Free cash flow | -58.32M | 35.75% |
About
CEO
Founded
2014
Website
Employees
680
